Reyedar BV.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Reyedar BV. - overview
Established
2019
Location
Groningen, -, Netherlands
Primary Industry
Healthcare Specialists
About
Based in the Netherlands, and founded in 2019, Reyedar BV. formerly known as Reperio Medtech, is a spin-off company of the Ophthalmology Department of the University Medical Center, and operates as a deep-tech company that offers accessible solutions for the screening of visual and neurodegenerative diseases. In July 2023, Reyedar raised EUR 3 million in seed funding led by Cottonwood Technology Fund, with participation from N. V.
NOM, Pupil Labs, Uneti Ventures, and returning investor Blue Sparrows MedTech Fund. As of July 2023, the company is led by its CEO, Dr. Alessandro Grillini. Reyedar BV offers AI-powered infrared eye-tracking glasses to measure eye movement reactions, which are analyzed by algorithms based on signal processing and deep neural networks.
The algorithm translates eye-tracking data into clinically relevant information and generates interpretive reports that include visual field sensitivity screening and qualitative risk indications for neuro visual disorders. The company plans to use the seed funding to expand its team and launch its eye care product as it moves to commercialize its technology.
Current Investors
Cottonwood Technology Fund, NOM, Blue Sparrows MedTech Fund
Primary Industry
Healthcare Specialists
Sub Industries
Optometrists & Opticians Products and Services
Website
www.reyedar.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Reyedar BV. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.